Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(72)
•••
Post by Humaniston Jan 20, 2021 10:17am
272 Views
Post# 32332983

SEEKING ALPHA: APHA TRADING 20% DISC TO TLRY! ENTRY POINT

SEEKING ALPHA: APHA TRADING 20% DISC TO TLRY! ENTRY POINT
Aphria: Trading At 20% Discount To Implied Price Of Tilray Deal
 January 20, 2021 - 9:48 AM EST
 
 
  • Aphria shares have gained 133% since the beginning of 2020 driven by better financial performance and two sound M&A deals.
  • The last quarter was unsurprising with stable cannabis revenue and the SweetWater acquisition will be fully captured next quarter.
  • Aphria shares are trading at a ~20% discount to the implied offer price based on the exchange ratio and Tilray share price, which offers an attractive entry point for investors.
For further details see:
Aphria: Trading At 20% Discount To Implied Price Of Tilray Deal
 
Source: SeekingAlpha (January 20, 2021 - 9:48 AM EST)
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities